|Basic InformationMore InformationLatest News|HIV No Barrier to Getting Liver Transplant, Study FindsImmune Cell Discovery May One Day Lead to Herpes Vaccine: StudyHalf of People With Hepatitis C Don't Complete Needed Tests: CDCNew Guidelines Suggest HIV Screening for All AdultsHIV 'Cure' Looks 'Promising,' Danish Scientists ContendSofosbuvir Shows Promise for Chronic Hepatitis C InfectionStudy Hints of Links Between HPV and Lung CancerCould Self-Testing Help Overcome HIV/AIDS Epidemic?Experimental Drug May Work Against Hepatitis CHIV Prevalence Is High Among High-Risk HeterosexualsCDC: 1 in 50 Poor, Straight Urban Americans Infected With HIVHIV Infection Linked to Risk of Acute Myocardial InfarctionHIV May Raise Risk of Heart AttackResearchers Describe 1st 'Functional Cure' of HIV in BabyU.S. AIDS-Relief Plan a Success, Report FindsMillions of Americans Have an STD: ReportCertain Skin Cancers More Common in HIV-Positive PeopleDrug Users Are 'Super-Spreaders' of Hepatitis C, Study FindsStudy Pinpoints Optimal Treatment Window for HIVGeneric Three-Pill HIV Regimen Could Result in Big SavingsSome HPV-Linked Cancers Rising in U.S.: ReportNew Pills Show Promise for Hepatitis CFulyzaq Approved for Diarrhea in People With HIV/AIDSHepatitis: The Hidden HazardSmoking Deadlier For HIV Patients Than Virus Itself: StudyKids With HIV at Risk of Heart Disease, Study SaysUse of Clinical Decision-Support System Can Improve HIV CareAmong Black Americans, HIV Takes a Greater TollNew HIV Infections Highest Among Urban Gay, Bisexual Men: CDCHIV Infections Continue to Hit Young Americans HardAIDS Deaths, New HIV Infections Continue to Drop WorldwideU.S. Task Force Backs HIV Screening for All 15 to 65Antiviral Therapy for Hepatitis C May Thwart Liver CancerHigh-Dose Vitamins Don't Halt HIV Progression, DeathExperimental Vaccine Might Help Women Already Infected With HPVMore Stomach, Esophageal Cancers Seen in AIDS Patients Than OthersScientists Probe How Some HIV Patients Resist AIDSImproved HIV Care Boosts Life Expectancy at Clinic, Study FoundAntiretrovirals Increasingly Used for HIV in the U.S.More Americans Get Effective HIV Treatment, Study SaysOnce-Daily Pill Approved to Treat HIVHepatitis C Treatment May Hamper Kids' GrowthGonorrhea Resistant to All But One Antibiotic: CDCNew Clues to How HIV Infects Body's CellsOnly 1 in 4 Americans With HIV Has Virus Under Control: CDCHIV Drug-Resistance Up in Resource-Limited SettingsAll HIV Patients Should Take Meds Early On, Experts Now SayMom's HIV Drugs May Pass to Baby in Womb, Breast-FeedingNot All HIV Patients in U.S. Show Same Characteristics: StudyHIV Racial Disparities Noted for Men Who Have Sex With MenQuestions and AnswersLinksBook Reviews
Antiretrovirals Increasingly Used for HIV in the U.S.
Updated: Sep 7th 2012
FRIDAY, Sept. 7 (HealthDay News) -- Since 2000, more HIV-infected patients in the United States are receiving antiretroviral treatment, viral load has fallen, and CD4 counts at death have risen, according to a study published in the Sept. 4 issue of the Annals of Internal Medicine.
Keri N. Althoff, Ph.D., M.P.H., from Johns Hopkins University in Baltimore, and colleagues analyzed data from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) on HIV treatment and health outcomes for 45,529 HIV-infected individuals receiving care in an NA-ACCORD participating clinical cohort in the United States from 2000 to 2008. The study population was demographically similar to the U.S. population living with HIV in 2008.
The researchers found that, by 2008, the percentage of patients receiving highly active antiretroviral therapy had increased significantly by 9 percentage points to 83 percent. The percentage of patients with suppressed HIV RNA plasma viral load (≤2.7 log10 copies/mL) increased significantly by 26 percentage points to 72 percent. In addition, median CD4 cell counts at death increased significantly, more than tripling to 0.209 × 109 cells/L.
"This is good news for the HIV epidemic in the United States, but there is room for improvement," Althoff said in a statement. "We need to continue to focus on linking HIV-infected adults into care and effective treatment, not only for the individual's health, but to reduce the likelihood of transmission to others."
Several authors disclosed financial ties to the pharmaceutical industry.
Full Text (subscription or payment may be required)
This article: Copyright © 2012 HealthDay. All rights reserved.